[Therapeutic study of efficiency and tolerance of bacampicine used in oto-rhino-laryngology].
High dose Bacampicin given alone to 50 patients for obvious clinical manifestation of severe ENT infections proved most satisfactory, with rapid improvement in physical and general conditions. Samples from 21 patients showed presence of germs, all being sensitive to Bacampicin. No sign of intolerance was noted. It follows from this result that in cases with patent signs of severe ENT infections, 800 mg Bacampicin given along morning and evening provides an effective and well tolerated treatment.
D000328:Adult; D000667:Ampicillin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010038:Otorhinolaryngologic Diseases / Q000188:drug therapy*
D000667:Ampicillin; C011674:bacampicillin
Etude thérapeutique de l'efficacité et de la tolérance de la bacampicine en ORL.